生物中國(guó)抗體仿制藥國(guó)際峰會(huì)2012將于6月在上海召開(kāi)
生物中國(guó)抗體仿制藥國(guó)際峰會(huì)2012
2012年6月26-27日 中國(guó).上海
BioChina International 2012
--- Capitalize on R&D and Bioprocessing Capabilities of
China’s Biopharma Industry and International Partnership
Date: June 26th - 27th, 2012
Location: Shanghai, China
Website: http://bci2012.
On the way to achieve antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all regulatory and quality standards. The key to overcome above challenges lies in bioprocess. Advancements on scale-up, pilot production, purification, expression technologies, quality control etc are some key issues that the industry stakeholders need to take into consideration when working on strategies to bring China’s biopharma industry into the next level . Apart from challenges in bioprocess technologies, China is working toward to better biosimilar and antibody R&D to fill limited product pipelines. With patent cliff for most of biologics in 2015, biosimilar has been recognized as great opportunities and major trends for future biopharma’s industry.
Riding on the booming biopharma industry in China, the inaugural BioChina International Conference 2012 is positioned to be the largest biopharma conference in China to focus on latest bioprocess and antibody advancement in China and globally. The content rich conference aims to build a definitive platform for biopharma industry leaders to gain proven strategies and solutions to finding new targets, optimizing epitope design for monoclonal antibody, scaling up both upstream and downstream processes, building pilot plant, advancing cell line development, improving quality and ensuring comparability of mAbs, biosimilars, biobetters and vaccines.
For more information, please contact Daniel Chen at 8621-32516046 or email daniel.chen@ for more information. Event website: http://bci2012./
- 因美納邀您參加CSCO第九屆血液腫瘤學(xué)術(shù)大會(huì)
- 千奧星科精彩亮相2025神經(jīng)科學(xué)技術(shù)研討會(huì)
- 諾達(dá)思攜多款產(chǎn)品亮相2025中國(guó)人類工效學(xué)學(xué)術(shù)會(huì)議
- 美森與您相約CMC-CHINA第七屆中國(guó)制藥工業(yè)博覽會(huì)
- CPHI&PMEC 2025制藥工業(yè)展（深圳）通知
- 2026第三十三屆成都醫(yī)療健康博覽會(huì)邀請(qǐng)函
- NGDx2025中國(guó)先進(jìn)診斷技術(shù)開(kāi)發(fā)與應(yīng)用論壇議程表
- 關(guān)于征集藥食同源及藥膳配方食品標(biāo)準(zhǔn)試點(diǎn)單位的通知
- 關(guān)于征集藥食同源優(yōu)選產(chǎn)品評(píng)價(jià)規(guī)范參編單位的通知
- QD中國(guó)攜單細(xì)胞方案亮相國(guó)際干細(xì)胞研究學(xué)會(huì)年會(huì)
- 維拓啟創(chuàng)助力2025表面肌電論壇在杭成功召開(kāi)
- 易科泰應(yīng)邀參加動(dòng)物遺傳專業(yè)委員會(huì)2025年學(xué)術(shù)年會(huì)
- 奧偉登攜前沿顯微技術(shù)亮相廈門2025中國(guó)材料大會(huì)
- CIIDC 2025中國(guó)（成都）儀器創(chuàng)新發(fā)展大會(huì)通知
- 2025新疆（昌吉）農(nóng)業(yè)展覽會(huì)即將震撼啟幕
- 杭州費(fèi)雪推出新品豬流行性腹瀉（PEDV）單克隆抗體
- Agrisera直播：從抗體選擇到WB全流程優(yōu)化策略
- MCE中國(guó)抗體實(shí)驗(yàn)圖征稿啟示，秀美圖贏AirPods
- 斯達(dá)特生物將亮相2025年美國(guó)AACR展會(huì)，誠(chéng)邀您蒞臨！
- MCE直播預(yù)告：銅死亡的機(jī)制探索與醫(yī)學(xué)應(yīng)用
- 2024第九屆疫苗中國(guó)領(lǐng)導(dǎo)者年會(huì)通知
- MCE推出超900種一抗和多種二抗產(chǎn)品，涵蓋熱門靶點(diǎn)
- 丹納赫將收購(gòu)Abcam以推動(dòng)生命科學(xué)領(lǐng)域研究創(chuàng)新進(jìn)程
- 睿捷生物新學(xué)期新福利，四重優(yōu)惠限時(shí)享
- 佰諾全景科研mIHC病理技術(shù)服務(wù)年中大促銷火熱來(lái)襲
- 西美杰KPL熱銷二抗和底物限時(shí)優(yōu)惠活動(dòng)已啟動(dòng)！
- 美國(guó)Jackson二抗產(chǎn)品暑期促銷
- PhytoAB推出調(diào)節(jié)ABA受體PYLs相關(guān)蛋白抗體
- 菲恩生物推出抗體等試劑產(chǎn)品五一節(jié)三重禮促銷活動(dòng)
- 2023疫苗創(chuàng)新國(guó)際論壇通知
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com